Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$323.56 - $373.36 $8.52 Million - $9.83 Million
-26,332 Reduced 72.77%
9,852 $3.68 Million
Q4 2022

Feb 14, 2023

BUY
$248.67 - $334.17 $5.02 Million - $6.74 Million
20,168 Added 125.92%
36,184 $12 Million
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $3.19 Million - $4.08 Million
12,094 Added 308.36%
16,016 $4.23 Million
Q2 2022

Aug 15, 2022

BUY
$301.4 - $428.42 $1.18 Million - $1.68 Million
3,922 New
3,922 $1.23 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $53.1 Million - $59.4 Million
-140,009 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$373.53 - $434.12 $17.9 Million - $20.8 Million
47,909 Added 52.02%
140,009 $58.7 Million
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $7.26 Million - $8.34 Million
18,300 Added 24.8%
92,100 $38.1 Million
Q2 2021

Aug 13, 2021

BUY
$372.36 - $412.07 $27.1 Million - $30 Million
72,700 Added 6609.09%
73,800 $29.2 Million
Q1 2021

May 14, 2021

SELL
$357.26 - $392.57 $11.3 Million - $12.4 Million
-31,500 Reduced 96.63%
1,100 $422,000
Q4 2020

Feb 12, 2021

BUY
$319.05 - $363.32 $10.4 Million - $11.8 Million
32,600 New
32,600 $11.8 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $6.82 Million - $8.46 Million
-24,340 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$270.93 - $320.3 $6.59 Million - $7.8 Million
24,340 New
24,340 $6.9 Million
Q1 2018

May 14, 2018

SELL
$218.74 - $251.43 $11.7 Million - $13.5 Million
-53,532 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$217.88 - $244.43 $11.7 Million - $13.1 Million
53,532
53,532 $11.7 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.